Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03328026
Title Rollover Study of SV-BR-1-GM in Combination With Ipilimumab or Pembrolizumab
Recruitment Enrolling by invitation
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors BriaCell Therapeutics Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
St. Joseph Heritage Healthcare Santa Rosa California 95403 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
University of Miami/Sylvester at Plantation Plantation Florida 33324 United States Details
Carle Cancer Institute Urbana Illinois 61801 United States Details
Cancer Center of Kansas (CCK) Wichita Kansas 67214 United States Details
The Center for Cancer and Blood Disorders a division of American Oncology Partners MD Bethesda Maryland 20817 United States Details
St Vincent-Frontier Cancer Center Billings Montana 59102 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Overlook Medical Center Oncology Research, Atlantic Health System Summit New Jersey 07901 United States Details
Manhattan Hematology Oncology Associates (MHOA) Manhattan New York 10016 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Tranquil Clinical Research Webster Texas 77598 United States Details
Hematology-Oncology Associates of Fredericksburg, Inc Fredericksburg Virginia 22408 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field